Physician profile
Phyllis E Weingarten
NPI 1336229350
$504.63
in general payments reported to CMS, 2019-2025
9 companies · $192 in 2025
The $192 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2022: $79.60 · 2023: $17.39 · 2024: $65.54 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $274.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $144.13 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $72.86 | 2019 | |
| Mallinckrodt Hospital Products INC. | $65.54 | 2024 | Acthar |
| Novartis Pharmaceuticals Corporation | $62.74 | 2019 | |
| Coopervision INC. | $54.64 | 2022 | |
| Recordati_rare_diseases_inc. | $47.79 | 2025 | Cystadrops |
| Ani Pharmaceuticals, INC. | $24.96 | 2022 | |
| Travere Therapeutics, INC. | $19.39 | 2019-2023 | Cholbam |
| Mallinckrodt Enterprises LLC | $12.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phyllis Weingarten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.